- Neptune Wellness Solutions press release ( NASDAQ: NEPT ): FY GAAP EPS of -$17.50.
- Revenue of $48.8M (+37.9% Y/Y).
- Previously announced planned divestiture of cannabis business expected to realize annualized payroll cost savings of $4.4M.
- "Neptune made significant progress on our path to become a pure play CPG company, with growth year-over-year and positive momentum in our key focus areas of Sprout and Biodroga during the fourth quarter. We expect this trend to continue into our fiscal 2023, with both Sprout and Biodroga continuing to expand their existing popular product offerings, as well as releasing new product lines that cater to different customer groups."
For further details see:
Neptune Wellness Solutions GAAP EPS of -$17.50, revenue of $48.8M